688068:SHA
Beijing Hotgen Biotech Co Ltd
84,54Â CNY
arrow_downward
-1,10%(-0,94) 1d
9 d’oct., 15:00:02 GMT+8 · CNY
search
Tots els sÃmbols
| SÃmbol | Preu | Canvi | Percentatge de canvi |
|---|
insights_autoS'estan generant les estadÃstiques principals per a 688068...
Obre
85,00Â CNY
Alt
85,54Â CNY
Baix
80,00Â CNY
Capitalització borsà ria
7841,43Â M
Volum mitjÃ
2,62Â M
Volum
3,17Â M
Alt 52 setmanes
214,78Â CNY
Baix 52 setmanes
73,44Â CNY
BPA
-3,00Â CNY
Nombre d'empleats
1Â k
Obre
85,00Â CNY
Alt
85,54Â CNY
Baix
80,00Â CNY
Capitalització borsà ria
7841,43Â M
Volum mitjÃ
2,62Â M
Volum
3,17Â M
Alt 52 setmanes
214,78Â CNY
Baix 52 setmanes
73,44Â CNY
BPA
-3,00Â CNY
Nombre d'empleats
1Â k
NotÃcies
De fonts web i partners de notÃcies
Kalkine Media
·
fa 1 hora
Why Does Strategy (NASDAQ:MSTR) Matter After the Rebound?
Benzinga
·
fa 56 minuts
S&P 500 Earnings Preview: Will Strong Profits Fuel the Next Rally?
Perfil
Hotgen Biotech, often simply referred to as Hotgen, is a Chinese biological technology company founded in 2005. It focuses on the manufacture of in-vitro diagnostic instruments and reagents. In September 2019, the company was listed on the Shanghai Stock Exchange. During the novel coronavirus pandemic, it specialized in making 2019-nCoV antigen diagnostic products, which obtained EU CE certification.
Hotgen was formerly a constituent of the STAR 50 Index. Headquartered in Beijing, it also established presences in foreign markets, such as the United Kingdom, France, and Germany. The net profit of the company in 2021 exceeded 2.3 billion yuan, an increase of more than sixteen times from the previous year. In 2022, its RAT kits were distributed free of charge by the Hong Kong Government to the public. In November 2023, it attended the MEDICA Trade Fair in Düsseldorf. Wikipedia
Sobre Beijing Hotgen Biotech Co Ltd